MAPT and Alzheimer disease: This is important, because Cdk5 is a protein kinase, whose deregulation contributes to synaptic loss and tau hyperphosphorylation in the AT8 epitope (present in the AD brain) after stimulation of Aβ fibrils [38, 39].